Speaker

Daniel Legg, MPH

boehringer-ingelheim
Daniel Legg, MPH

Biography

Daniel Legg is the U.S. Early Asset Lead for the CardioRenal and Metabolic therapeutic area and Clinical Development Lead for liver disease at Boehringer Ingelheim. He is passionate about advancing science to address unmet medical needs and is honored to share insights on early asset development and clinical strategy at AASLD.

Sessions

8:00 AM - 9:30 AM
Nov 07 2025
Washington, D.C.

Patient Engagement as a HABIT: Hope in Action — Breaking Barriers, Impactful Transitions

Robert Mitchell-Thain, Presenter
Jenn L Jones, BA Communication Studies, Presenter
Vijay H. Shah, MD, FAASLD, Presenter
Robert Gish, MD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cholestatic and Autoimmune
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Hepatology Associates
Liver Cancer
MASLD
Patient Program
Pediatrics
Trainee
Transplant